Cite
HARVARD Citation
Sferrazza, G. et al. (2017). Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations. Expert review of clinical pharmacology. 10 (9), pp. 1007-1019. [Online].